Biotech

All Articles

Life science credit rating organization unveils with $600M

.A new worldwide lifestyle scientific research credit organization, termed Symbiotic Financing, has ...

BMS ditches TIGIT, ignoring $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing another major wager from the Caforio age, terminating a deal for Agen...

Nuvation standstills BET prevention after thinking about stage 1 record

.After looking at phase 1 data, Nuvation Biography has actually chosen to halt focus on its own one-...

' Clinical instinct' led FDA advisors to back Zevra's uncommon illness med

.Zevra Rehabs' rare health condition medication appears to be on the course to authorization this fa...

Pfizer takes $230M hit after axing failed DMD gene treatment

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics therapy failing has gone a $230 million ...

AC Immune observes 'spots' prospective in Alzheimer's medicine records

.After greater than 20 years of focus on neurodegenerative illness, Swiss biotech air conditioner Im...

GSK goes down ph. 2 HPV vaccine over lack of best-in-class prospective

.GSK has actually scrapped a period 2 human papillomavirus (HPV) injection coming from its own pipel...

OS Therapies refiles $6M IPO to cash HER2 medication, preclinical ADCs

.Operating system Therapies will list on the NYSE American inventory exchange this morning via a $6....

ALX's waning CD47 action price delivers stock spiraling down

.ALX Oncology's stage 2 stomach cancer action price has damaged. After finding its own CD47 blocker ...

Ionis centers eye disease coming from targets of Roche-partnered prospect after information disappoint

.An Additional of Ionis Pharmaceuticals' key midphase readouts has disappointed assumptions, motivat...